Chronic lymphocytic leukemia (CLL) is a type of blood cancer that affects white blood cells called lymphocytes. There are many types of leukemia, and CLL is a common type in adults. This type of ...
AbbVie is seeking a new way to fight chronic lymphocytic leukemia, or CLL, by combining its oncology drug Venclexta with another cancer-fighting drug. The North Chicago-based drugmaker has filed a ...
What Is It, and Why Does It Matter? The FDA has approved a new combination treatment for adults with certain cancers of the blood and lymphatic system. The targeted regimen combines Calquence ...
First all-oral, fixed-duration combination regimen approved for previously untreated patients with CLL Approval supported by data from the Phase 3 AMPLIFY trial Regimen offers another option for the ...
Data Trends provide quick, visually memorable data-driven information and insights that are useful in clinical practice. Here, we explore recent treatment updates in chronic lymphocytic leukemia (CLL) ...
Hosted on MSN
Cancer study buoys these small biotechs
The effectiveness of a leukemia drug from Terns Pharmaceuticals exceeded the hopes of many doctors and investors when the biotech firm reported early phase trial results this week. Terns shares jumped ...
Regulatory filings show that Terns ultimately accepted an offer 15% lower than a previous proposal as four companies vied for ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Bexobrutideg could win FDA ...
A once-dismissed idea that a single pill could stop cancer now shapes how doctors treat the disease. This week, Oregon Health ...
Another bidder, which remains unidentified, dropped out of the bidding process. Analysts at William Blair now think it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results